23 08, 2023 Maria Raffaella Ambrosio et al., Immune landscape and oncobiota in HPV-Associated Colorectal Cancer: an explorative study adlitterio663392023-08-23T09:33:37+02:00 Read More
1 08, 2023 Caterina Fumagalli et al., Molecular testing in indeterminate thyroid nodules: an additional tool for clinical decision-making adlitterio663392023-08-01T09:38:22+02:00 Read More
28 07, 2023 Leo Guidobaldi et al., Primary Thyroid Lymphoma: How Molecular Biology and Ancillary Techniques Can Help the Cytopathologist Overcome This Diagnostic Challenge adlitterio663392023-07-28T09:29:08+02:00 Read More
14 07, 2023 Alessandro Pancrazzi et al., BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings adlitterio663392023-10-17T09:23:04+02:00 Read More
16 05, 2023 Daniela Massi et al., Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group. adlitterio663392023-10-17T09:13:02+02:00 Read More
4 05, 2023 Federica Zito Marino et al., NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS. adlitterio663392023-10-17T09:08:15+02:00 Read More
30 03, 2023 Margherita Vannucchi et al., KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma adlitterio663392023-10-17T09:04:54+02:00 Read More
21 03, 2023 Mara Colombo et al., A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report adlitterio663392023-03-21T16:36:24+01:00 Read More
20 03, 2023 Roberto Liserre et al., Exceptionally rare IDH1-mutant adult medulloblastoma with concurrent GNAS mutation revealed by in vivo magnetic resonance spectroscopy and deep sequencing adlitterio663392023-10-17T09:03:23+02:00 Read More
28 09, 2022 Silvia Chiesa et al., Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma adlitterio663392022-10-13T15:41:55+02:00 Read More